Categories AlphaGraphs, Earnings, Health Care

Key highlights from SmileDirectClub (SDC) Q1 2020 earnings results

SmileDirectClub, Inc. (NASDAQ: SDC) reported its financial results for the quarter ended March 31, 2020, on Wednesday after the market closes. The bottom line was wider than the analysts’ expectations while the top line missed consensus estimates.

SmileDirectClub posted a wider loss in the first quarter of 2020 due to higher costs and expenses. However, the top-line increased by 11% year-over-year driven by an increase in unique aligner shipments and higher average aligner gross sales price.

SmileDirectClub (SDC) Q1 2020 earnings review

Due to very few fixed costs and the vast majority of its SmileShops around the world operate on month-to-month leases, the company has been able to take decisive action, including the temporary closure of all SmileShops other than those in Hong Kong. The company has also put in place several cost management measures, including the suspension of most of its marketing spend, to position it to operate cash-neutral during this period.

Also, SmileDirectClub has entered into a new debt facility with HPS Investment Partners. After refinancing the previous debt facility, the company will have about $420 million in cash on its balance sheet, giving the liquidity needed to continue its growth plans and manage potential downsides with COVID-19.

Take a look at our Health Care articles here

Most Popular

Microsoft (MSFT) reports higher revenue and profit for Q3 2024

Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,

GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results

Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was

MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top